ロード中...
Combinational therapy of crizotinib and afatinib for malignant pleural mesothelioma
Malignant pleural mesothelioma (MPM) is a relative rare but highly aggressive neoplasm which is associated with asbestos exposure in most patients. The majority of patients are diagnosed in advanced stages so patients neither benefit from chemotherapy (e.g. pemetrexed-platinum combination) nor from...
保存先:
| 出版年: | Am J Cancer Res |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
e-Century Publishing Corporation
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5336496/ https://ncbi.nlm.nih.gov/pubmed/28337371 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|